rhod-2 has been researched along with vesnarinone in 1 studies
| Studies (rhod-2) | Trials (rhod-2) | Recent Studies (post-2010) (rhod-2) | Studies (vesnarinone) | Trials (vesnarinone) | Recent Studies (post-2010) (vesnarinone) |
|---|---|---|---|---|---|
| 107 | 0 | 21 | 215 | 17 | 8 |
| Protein | Taxonomy | rhod-2 (IC50) | vesnarinone (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.0965 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 6.2 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cowan, DB; del Nido, PJ; McGowan, FX; Munakata, M; Poutias, DN; Takeuchi, K | 1 |
1 other study(ies) available for rhod-2 and vesnarinone
| Article | Year |
|---|---|
Vesnarinone restores contractility and calcium handling in early endotoxemia.
Topics: Animals; Calcium; Cardiac Pacing, Artificial; Cardiotonic Agents; Disease Models, Animal; Endotoxemia; Fluorescent Dyes; Heterocyclic Compounds, 3-Ring; In Vitro Techniques; Infusions, Intravenous; Intracellular Fluid; Lipopolysaccharides; Myocardial Contraction; Oxygen Consumption; Pyrazines; Quinolines; Rabbits; Ventricular Function, Left | 2000 |